Renaissance Technologies
CNST

Renaissance Technologies’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Renaissance Technologies’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31,600
Closed -$950K – 3820
2020
Q2 		$950K Buy
+31,600
New +$1.14M ﹤0.01% 2565
2020
Q1 		– Sell
-93,779
Closed -$4.42M – 3962
2019
Q4 		$4.42M Buy
+93,779
New +$2.71M ﹤0.01% 1926

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Renaissance Technologies's CNST Position: Q3 2020 in Review

Renaissance Technologies sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2020, closing a stake of 31,600 shares — an estimated $950K sold.

Renaissance Technologies first reported a position in CNST in Q4 2019 and held it in 2 quarters. The position peaked at $4.42M in Q4 2019. 119 funds tracked by Wall St. Rank hold CNST as of Q3 2020.

  • Renaissance Technologies reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Renaissance Technologies sold 31,600 Constellation Pharmaceuticals, Inc. shares in Q3 2020, an estimated $950K.
  • Renaissance Technologies first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 2 quarters.
  • Renaissance Technologies's Constellation Pharmaceuticals, Inc. position peaked at $4.42M in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2020.

Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.